#epigenetic-reprogramming News & Analysis

2 articles tagged with #epigenetic-reprogramming. AI-curated summaries with sentiment analysis and key takeaways from 50+ sources.

2 articles

GeneralBullishBlockonomi · 4h ago7/10

📰

NewLimit Series C: Armstrong-Backed Longevity Startup Raises $435M

NewLimit, a longevity biotech startup backed by Neil Armstrong's family, raised $435M in Series C funding led by Founders Fund to advance epigenetic reprogramming therapies. The company plans to initiate first-in-human clinical trials for its lead liver cell regeneration program next year following recent breakthrough research results.

GeneralNeutralBlockonomi · 2h ago5/10

📰

Brian Armstrong’s Anti-Aging Venture NewLimit Secures $435M in Massive Funding Round

Coinbase CEO Brian Armstrong's longevity startup NewLimit has raised $435 million at a $3.1 billion valuation, signaling substantial institutional confidence in epigenetic reprogramming technology. The company plans to begin human trials for its anti-aging technology in 2027, marking a significant milestone in the commercialization of longevity science.